CompaniesMIP Diagnostics

MIP Diagnostics

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

3

As Collaborator

1

Total Enrollment

3,302

By Phase

NA: 2

By Status

RECRUITING: 3COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT04109625
NCT06082336
Hover over trial bars to see details

Recent Trials

NCT07170748Lead Sponsor
Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
N/ARecruiting
2,950 participants
Started: Oct 31, 2025 · Completed: Mar 31, 2026
NCT06899113Lead Sponsor
Correlating Multispectral Near-Infrared Imaging to Standard Vascular Diagnostics
N/ARecruiting
60 participants
Started: May 13, 2025 · Completed: Dec 31, 2025
NCT06082336Lead Sponsor
Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C
NARecruiting
252 participants
Started: Jan 23, 2023 · Completed: Sep 30, 2024
NCT04109625Collaborator
Preliminary Validation of an in Vitro Diagnosis-medical Device for Hepatitis B Screening
NACompleted
40 participants
Started: Oct 21, 2019 · Completed: May 13, 2022